UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:June 23,
Cyclerion Therapeutics (NASDAQ:CYCN)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Cyclerion Therapeutics Charts.
Cyclerion Therapeutics (NASDAQ:CYCN)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Cyclerion Therapeutics Charts.

Cyclerion Therapeutics, Inc. News

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 27 January 2024 (3 months ago) • Edgar (US Regulatory)
Form 3 - Initial statement of beneficial ownership of securities
Tuesday 12 December 2023 (5 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 5 December 2023 (5 months ago) • Edgar (US Regulatory)
Cyclerion Appoints Regina Graul, Ph.D., as President
Tuesday 5 December 2023 (5 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Saturday 2 December 2023 (5 months ago) • Edgar (US Regulatory)
Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator
Friday 1 December 2023 (5 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Saturday 25 November 2023 (5 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 14 November 2023 (6 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 24 October 2023 (6 months ago) • Edgar (US Regulatory)
Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets
Monday 31 July 2023 (9 months ago) • GlobeNewswire Inc.
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 29 July 2023 (9 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 20 July 2023 (9 months ago) • Edgar (US Regulatory)

More Cyclerion Therapeutics, Inc. News Articles